COX‐2 acts in the tumor microenvironment (TME) through a variety of mechanisms, such as inhibiting tumor cell apoptosis, promoting prostaglandin E2 (PGE2) release, and inducing IDO1 production [77]. Here, PTGS2 is linked to neoplasm.